131 related articles for article (PubMed ID: 18469837)
1. Why metabolic syndrome criteria have not made prime time: a view from the clinic.
Sattar N
Int J Obes (Lond); 2008 May; 32 Suppl 2():S30-4. PubMed ID: 18469837
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome: should current criteria influence clinical practice?
Sattar N
Curr Opin Lipidol; 2006 Aug; 17(4):404-11. PubMed ID: 16832164
[TBL] [Abstract][Full Text] [Related]
3. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
4. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
[TBL] [Abstract][Full Text] [Related]
5. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.
Smith SR
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():128S-134S. PubMed ID: 16931494
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome and risk of cardiovascular disease and diabetes: experiences with the new diagnostic criteria from the International Diabetes Federation.
Saely CH; Rein P; Drexel H
Horm Metab Res; 2007 Sep; 39(9):642-50. PubMed ID: 17846971
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
Zarich SW
Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
[TBL] [Abstract][Full Text] [Related]
8. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
[TBL] [Abstract][Full Text] [Related]
9. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
10. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
Cannon CP
Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
Steiner G
Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
13. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
Jones PH
Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
[TBL] [Abstract][Full Text] [Related]
14. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
de Zeeuw D; Bakker SJ
Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S10-4. PubMed ID: 18580860
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
Sattar N
Minerva Endocrinol; 2005 Sep; 30(3):121-38. PubMed ID: 16208304
[TBL] [Abstract][Full Text] [Related]
16. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.
Choi HK; De Vera MA; Krishnan E
Rheumatology (Oxford); 2008 Oct; 47(10):1567-70. PubMed ID: 18710901
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
18. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
Battista M; Murray RD; Daniels SR
Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome.
Haddad FH; Mahafza SM
Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
